Clinical Trials

Prostatic Neoplasms

NCT00756509 2026-01-20

Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib

34 enrolled 11 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05457257 2025-12-19

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT05687032 2025-12-03

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

44 enrolled 14 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02625389 2025-10-10

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

132 enrolled 9 charts

Sarcoma

Arteriovenous Malformations, Hemangioendothelioma, Hemangiosarcoma

NCT01496313 2025-10-03

To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer

81 enrolled 15 charts

Head & Neck

Neoplasm Metastasis, Thyroid Neoplasms, Carcinoma, Medullary

NCT04319198 2025-09-30

Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy

25 enrolled 15 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT01909934 2025-09-19

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

50 enrolled 22 charts

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT05442554 2025-09-18

A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

10 enrolled 25 charts

Lymphoma, T-Cell

NCT05219162 2025-09-11

GPS

182 enrolled 11 charts

Phase 4 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT01896479 2025-09-02

EXAMINER

247 enrolled 14 charts

Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

NCT03715205 2025-08-29

Keynote-593

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03934684 2025-08-06

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

101 enrolled 11 charts

Plasma cell

Multiple Myeloma

NCT04513522 2025-07-11

CheckMate 7C9

101 enrolled 12 charts

Kidney Neoplasms

NCT04489888 2025-06-19

MK-3475-B10

101 enrolled 14 charts

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

NCT04362072 2025-06-11

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

71 enrolled 26 charts

Tumor-Agnostic

Carcinoma

NCT03190330 2025-05-25

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

75 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT04042376 2025-05-25

A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

17 enrolled 15 charts

Waldenstrom Macroglobulinemia

NCT01673984 2025-05-23

GREAT

Phase 4 Terminated

27 enrolled 13 charts

Prostatic Neoplasms

NCT04506086 2025-05-18

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase 4 Terminated

10 enrolled 12 charts

Leukemia, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03641560 2025-04-08

A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

52 enrolled 10 charts

Metastatic Castration Resistant Prostate Cancer

NCT02312960 2025-03-25

Radium-223 Dichloride Long-term Follow-up Program

255 enrolled 31 charts

Tumor-Agnostic

Neoplasm Metastasis

NCT04060654 2025-03-25

SUBLOCADE Rapid Initiation Extension Study

17 enrolled 12 charts

Lymphoma, Follicular, Opioid-Related Disorders

NCT04330040 2025-03-10

SOLI

202 enrolled 15 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT01926496 2025-03-07

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

485 enrolled 17 charts

Dermatologic

Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

334 enrolled 12 charts

Dermatologic

Keratosis, Keratosis, Actinic

NCT02842749 2025-02-10

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

EndocrineGastrointestinalNET

61 enrolled 9 charts

Pancreatic Neuroendocrine Tumors

NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

1 enrolled 1 chart

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT05848947 2025-01-29

MAApping

5 enrolled 9 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT04524442 2025-01-24

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

EndocrineGastrointestinalNET

42 enrolled 11 charts

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Neuroendocrine Tumors

NCT03285763 2025-01-23

TAIL

619 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

NCT04526704 2024-12-30

PLX3397

32 enrolled 15 charts

Giant Cell Tumor of Tendon Sheath

NCT04078152 2024-12-20

WAVE

163 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04541706 2024-12-20

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

100 enrolled 10 charts

Advanced Non-Small Cell Lung Cancer

NCT02918968 2024-12-09

Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer

206 enrolled 16 charts

Prostatic Neoplasms

NCT01977651 2024-12-06

UPWARD

424 enrolled 10 charts

Seizures

NCT02116582 2024-12-06

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

215 enrolled 11 charts

Metastatic Castration-Resistant Prostate Cancer

NCT03035032 2024-11-26

A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

107 enrolled 25 charts

Prostatic Neoplasms

NCT04825574 2024-11-26

Study for Patients Previously Treated in Avapritinib Clinical Trials

2 enrolled 4 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04930536 2024-11-22

Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

103 enrolled 10 charts

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT03672643 2024-11-08

Long Term Safety Observation of Crizotinib in Chinese NSCLC Population

Phase 4 Terminated

41 enrolled 9 charts

ALK or ROS1-positive NSCLC

NCT04416633 2024-11-08

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

100 enrolled 11 charts

Unresectable Non-small Cell Lung Cancer (NSCLC)

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

DermatologicEndocrineGenitourinaryNET

337 enrolled 8 charts

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT03301857 2024-05-20

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

85 enrolled 13 charts

Giant Cell Tumor of Bone

NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

338 enrolled 21 charts

Tumor-Agnostic

Neoplasms

NCT04511533 2024-04-05

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

101 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

6,051 enrolled 11 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01735955 2024-02-08

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

GastrointestinalLymphoidMyeloidOther hematologic neoplasmSarcoma

57 enrolled 8 charts

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Piebaldism, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04555044 2023-12-27

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)